Panacea Biotec Ltd (PNCA.NS)
PNCA.NS on National Stock Exchange of India
108.25INR
17 May 2013
108.25INR
17 May 2013
Price Change (% chg)
Rs-1.05 (-0.96%)
Rs-1.05 (-0.96%)
Prev Close
Rs119.85
Rs119.85
Open
Rs109.00
Rs109.00
Day's High
Rs112.00
Rs112.00
Day's Low
Rs107.60
Rs107.60
Volume
14,384
14,384
Avg. Vol
54,429
54,429
52-wk High
Rs158.20
Rs158.20
52-wk Low
Rs64.00
Rs64.00
PNCA.NS
About
Panacea Biotec Limited is an India-based pharmaceutical company. The Company is a research based company engaged in the business of research, development, manufacture and marketing of vaccines and branded pharmaceutical formulations. The Company has products for various segments, which include pediatric vaccines, pain management... (more)
No analyst recommendations are available for PNCA.NS.
Overall
| Beta: | 1.62 |
| Market Cap (Mil.): | Rs6,630.39 |
| Shares Outstanding (Mil.): | 61.25 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| PNCA.NS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 35.66 | 35.83 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | 19.36 | 18.72 |
| ROE: | -- | 20.07 | 19.54 |
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
